ESR1 and invasive breast carcinoma: Triple-negative breast cancers (TNBC), an aggressive form of breast cancer that lacks significant expression of the human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR), accounts for approximately 15~20% of invasive breast cancers.